Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11053485 MAD nucleases

Patent 11053485 was granted and assigned to Inscripta on July, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Inscripta

Current Assignee

Inscripta

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

110534850

Patent Inventor Names

Kyle Seamon0

Aamir Mir0

Andrew Garst0

Benjamin Mijts0

Juhan Kim0

Date of Patent

July 6, 2021

Patent Application Number

170845220

Date Filed

October 29, 2020

Patent Citations

‌

US Patent 10017760 Methods for generating barcoded combinatorial libraries

‌

US Patent 10011849 Nucleic acid-guided nucleases

‌

US Patent 10266851 Using programmable DNA binding proteins to enhance targeted genome modification

Patent Citations Received

‌

US Patent 11884924 Dual strand nucleic acid-guided nickase editing

‌

US Patent 11306298 Mad nucleases

Patent Primary Examiner

‌

Nancy J Leith

Patent abstract

The present disclosure provides new RNA-guided nucleases for making rational, direct edits to nucleic acids in live cells.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11053485 MAD nucleases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API